Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
19.79
+0.04 (0.20%)
At close: Nov 10, 2026, 4:00 PM EST
19.59
-0.20 (-0.99%)
After-hours: Nov 10, 2026, 5:36 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $1.23 billion as of November 10, 2026. Its market cap has increased by 296.07% in one year.
Market Cap
1.23B
Enterprise Value
1.16B
1-Year Change
296.07%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has increased from $538.37M to $1.23B, an increase of 128.65%. That is a compound annual growth rate of 14.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 1.23B | 328.65% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MannKind | 1.35B |
| GH Research | 1.32B |
| Avalyn Pharma | 1.31B |
| Alpha Tau Medical | 1.30B |
| Nektar Therapeutics | 1.29B |
| UroGen Pharma | 1.29B |
| SpyGlass Pharma | 1.28B |
| Savara | 1.28B |